Isnani, Cristine M.

HRN: 28-57-99  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/21/2026
MUPIROCIN 2%, 15G (TUBE)
03/21/2026
03/27/2026
TOPICAL
1ml
OD
SP CS
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: